Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02974231

Enrollment

240

Registered

2016-11-28

Start date

2014-12-31

Completion date

2015-03-31

Last updated

2016-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

The objective is to report outcomes,including grade ≥2 overall late rectal and urinary toxicity and biochemical control rates in patients treated with IMRT (70 gy, 74 Gy and 80 Gy)

Interventions

RADIATIONIntensity-modulated radiation therapy

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Consecutive patients from June 2000 to December 2010 with * untreated histologically confirmed adenocarcinoma of the prostate * stage T1c-T4 N0 M0 according to the 1992 American Joint Committee on Cancer staging system

Exclusion criteria

* Patients with positive pelvic lymphadenectomy or radiological positives nodes

Design outcomes

Primary

Measure	Time frame
grade≥ 2 overall late rectal 5 years after the end of radiotherapy	60 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026